Drugs.com - Pharma Industry News

AAAAI: Omalizumab Superior to Oral Immunotherapy in Multifood Allergy

MONDAY, March 3, 2025 -- Omalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC) of allergy-triggering foods after gaining tolerance, according to two studies presented at the...

Mar 3, 2025 - 21:21
 0
AAAAI: Omalizumab Superior to Oral Immunotherapy in Multifood Allergy
MONDAY, March 3, 2025 -- Omalizumab is superior to oral immunotherapy (OIT) for multifood allergy, and most patients include dietary consumption (DC) of allergy-triggering foods after gaining tolerance, according to two studies presented at the...
Read More

Tags:

Previous Article

The Hottest Fragrances And Trends At Indie Perfume Shops Across The Country

Next Article

Air Force pauses deliveries of Boeing’s KC-46 tanker

Related Posts

Higher Calcium Intake Linked to Reduced Colorectal Cancer Risk

Higher Calcium Intake Linked to Reduced Colorectal Canc...

Feb 21, 2025  0

Use of Secondary CVD Prevention Medications Low in Most Countries

Use of Secondary CVD Prevention Medications Low in Most...

Feb 12, 2025  0

Racial, Ethnic Disparities Seen in Counseling for Children With High BP

Racial, Ethnic Disparities Seen in Counseling for Child...

Feb 9, 2025  0